[CT 1341, a new anesthetic agent].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000768:Anesthesia, General; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D002648:Child; D003916:Dextromoramide / Q000494:pharmacology; D004338:Drug Combinations; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006900:Hydroxylation; D007275:Injections, Intravenous; D007659:Ketones / Q000494:pharmacology*; D008875:Middle Aged; D009129:Muscle Tonus / Q000187:drug effects; D011229:Preanesthetic Medication; D011277:Pregnanediones / Q000494:pharmacology*; D011278:Pregnanes / Q000494:pharmacology*; D012119:Respiration / Q000187:drug effects
D004338:Drug Combinations; D007659:Ketones; D011277:Pregnanediones; D011278:Pregnanes; D003916:Dextromoramide
Le CT 1341, nouvel agent anesthésique.